|Previous Section||Index||Home Page|
Mr. Heald: To ask the Secretary of State for Health if he will make a statement on the Electronic Record Development and Implementation Programme with regards to the national rollout of electronic personal medical records for all patients. 
12 Jul 2002 : Column 1281W
electronic record programme specified in the information strategy Information for Health, published in September 1998. The programme consisted of 19 projects, nine of which have now completed. The projects ranged in size from one to exchange information between NHS Direct and general practitioner (GP) systems, to a pan community service covering a health authority (as previously defined), linking hospitals, general practice, ambulance and social care. Two general practices (Bury Knowle and Hatfield) have explored the issues of allowing patients access to their own GP records.
Mr. Lammy [holding answer 10 July 2002]: At present no official figures are available on the proportion of patients who have been given direct on-line, secure access to their electronic record. However, there are a number of sites that have taken forward work in this area, which will inform policy development and any future national rollout.
In addition proposal are currently being considered to take forward the development of an electronic personal health record as specified in the National Health Service information strategy, Information for Health. This will be the patient's own record, separate from the general practice and hospital records.
Mr. Lammy: The National Institute for Clinical Excellence (NICE) are carrying out an appraisal of photodynamic therapy as a treatment for age related macular degeneration. NICE published its final appraisal determination on photodynamic therapy on 12 June. This has been appealed against. An appeal panel will now be convened to hear the appeal and decide the outcome. If the appeal is not upheld, then guidance will be published, however, if it is upheld then the appeals panel will ask the appraisal committee to reconsider the evidence in light of the appeal panel's decision. The earliest guidance could be available to the National Health Service is early August.
Mr. Hutton: All mental health wards generally care for both men and women. To provide the required levels of privacy and dignity for patients, wards are split into single sex bays, or single rooms, or otherwise configured to provide adequate segregation of gender. It is the responsibility of each National Health Service trust to determine the most appropriate configuration to meet their specific requirements.
12 Jul 2002 : Column 1282W
Mr. Hutton: The national director for mental health's working group has taken a number of practical steps related to the recruitment and retention of psychiatrists. The group has initiated an attrition study of psychiatric trainees, a study of flexible trainees in psychiatry, a survey into the retirement intentions of consultant psychiatrists and a study of psychiatrists' workload. The group has provided psychiatric input to international recruitment and work is in progress to recruit psychiatrists through the general global recruitment campaign and the International Fellowship scheme.
Mr. Heald: To ask the Secretary of State for Health how many more staff will need to be recruited to acute mental health wards as a result of implementation of the Working Time Regulations; and if he will make a statement as to his plans. 
Jacqui Smith: This information is not currently available centrally. The mental health service mapping system is being refined to enable the Department to gauge progress against this NHS Plan commitment.
12 Jul 2002 : Column 1283W
Mr. Lammy: Neither Ziprasidone nor Aripiprazole are licensed drugs in the United Kingdom. These products will become available for prescription once the licensing authority is satisfied of their quality, safety and efficacy for the intended use.
Mr. Hancock: To ask the Secretary of State for Health how many psychiatric outpatients from the Portsmouth, South constituency have committed suicide in the last five years; and if he will make a statement. 
Mr. Lammy: We welcome the MIND prescribing protocol. The themes highlighted are in line with action we are taking to improve the use of medicines in the National Health Service through medicines management schemes and patient partnership.
Mr. Lammy: The main Government agency for medical research is the Medical Research Council (MRC), which is funded via the Department of Trade and Industry. The MRC currently supports one research project on electro convulsive therapy (ECT) being undertaken by Dr. M. J. Koepp at the Institute of Neurology. The research started on 1 November 2001 and is expected to take three years.
The Department directly funds research into policy and the delivery of effective practice in health and social care, and provides National Health Service support funding for research commissioned by the research councils and charities in the NHS. The Department has directly funded research projects relevant to ECT as follows:
12 Jul 2002 : Column 1284W
|Next Section||Index||Home Page|